Wockhardt expands global reach with new step-down subsidiaries

Wockhardt Bio AG, a subsidiary of Wockhardt Limited, has incorporated three new wholly-owned step-down subsidiaries: Wockhardt Suisse AG (Switzerland), Wockhardt Suisse USA Holding Corporation (USA), and Wockhardt Suisse USA LLC (USA). Wockhardt Suisse AG was incorporated on December 1, 2025, in Zug, Switzerland, with a capital of CHF 100,000.00. Wockhardt Suisse USA Holding Corporation and Wockhardt Suisse USA LLC were both incorporated on December 11, 2025, in Delaware, USA, each with a capital of $50,000.00.

These new entities align with Wockhardt's main business objectives, primarily to channelize the company’s antibiotic products. Wockhardt Suisse USA Holding Corporation and Wockhardt Suisse USA LLC will specifically focus on expanding the distribution of antibiotic and other products across the United States. All three entities are yet to commence business operations.

The incorporations were made through cash consideration. Wockhardt Suisse AG is 100% held by Wockhardt Bio AG. Wockhardt Suisse USA Holding Corporation is 100% held by Wockhardt Suisse AG, and Wockhardt Suisse USA LLC is 100% held by Wockhardt Suisse USA Holding Corporation, solidifying the multi-tiered subsidiary structure.